Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GV1001 plus gemcitabine/capecitabine vs gemcitabine/capecitabine in advanced pancreatic cancer
KCT0002159Phase 3Recruiting
- Sponsor
- Samsung Pharmaceutical
- Start
- Nov 2015
- Modality
- Vaccines & Immunotherapeutics, Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of tertomotide in pancreatic cancer (PC), sponsored by Samsung Pharmaceutical. Started Nov 2015; status: recruiting.
02
Drugs
tertomotide
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on KCT0002159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0002159.